103 related articles for article (PubMed ID: 35882906)
1. High levels of TIMP1 are associated with increased extracellular matrix stiffness in isocitrate dehydrogenase 1-wild type gliomas.
Luo CH; Shi Y; Liu YQ; Liu Q; Mao M; Luo M; Yang KD; Wang WY; Chen C; Niu Q; Yan ZX; Miao JY; Zhang XN; Zeng H; Li L; Bian XW; Ping YF
Lab Invest; 2022 Dec; 102(12):1304-1313. PubMed ID: 35882906
[TBL] [Abstract][Full Text] [Related]
2. IDH1
Han X; Zhou H; Sun W; Hou L; Wang Y; Wang H; Lv Z; Xue X
Sci Rep; 2023 Nov; 13(1):19659. PubMed ID: 37952042
[TBL] [Abstract][Full Text] [Related]
3. Isocitrate Dehydrogenase Mutations Are Associated with Different Expression and DNA Methylation Patterns of OLIG2 in Adult Gliomas.
Mo H; Magaki S; Deisch JK; Raghavan R
J Neuropathol Exp Neurol; 2022 Aug; 81(9):707-716. PubMed ID: 35856894
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors.
Perycz M; Dabrowski MJ; Jardanowska-Kotuniak M; Roura AJ; Gielniewski B; Stepniak K; Dramiński M; Ciechomska IA; Kaminska B; Wojtas B
Acta Neuropathol Commun; 2024 May; 12(1):72. PubMed ID: 38711090
[TBL] [Abstract][Full Text] [Related]
5. IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.
Fujita Y; Nunez-Rubiano L; Dono A; Bellman A; Shah M; Rodriguez JC; Putluri V; Kamal AHM; Putluri N; Riascos RF; Zhu JJ; Esquenazi Y; Ballester LY
J Neurooncol; 2022 Sep; 159(2):261-270. PubMed ID: 35816267
[TBL] [Abstract][Full Text] [Related]
6. Mutant Isocitrate Dehydrogenase 1 Expression Enhances Response of Gliomas to the Histone Deacetylase Inhibitor Belinostat.
Chang CM; Ramesh KK; Huang V; Gurbani S; Kleinberg LR; Weinberg BD; Shim H; Shu HG
Tomography; 2023 May; 9(3):942-954. PubMed ID: 37218937
[TBL] [Abstract][Full Text] [Related]
7. Using quantitative MRI to study the association of isocitrate dehydrogenase (IDH) status with oxygen metabolism and cellular structure changes in glioma.
Qiu J; Wu K; Zhu M; Chen CY; Luo Y; Liu Y; Wen J
Eur J Radiol; 2022 Oct; 155():110502. PubMed ID: 36049408
[TBL] [Abstract][Full Text] [Related]
8. Detection of IDH1 Mutation in cfDNA and Tissue of Adult Diffuse Glioma with Allele-Specific qPCR.
Husain A; Mishra S; Siddiqui MH; Husain N
Asian Pac J Cancer Prev; 2023 Mar; 24(3):961-968. PubMed ID: 36974551
[TBL] [Abstract][Full Text] [Related]
9. Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures.
Shmelev ME; Farniev VM; Shved NA; Kumeiko VV
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835465
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Matrisome-Associatted Gene Expressions with LOX Family Members in Astrocytomas Stratified by IDH Mutation Status.
Laurentino TS; Soares RDS; Marie SKN; Oba-Shinjo SM
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076905
[TBL] [Abstract][Full Text] [Related]
11. Partial erosion on under-methylated regions and chromatin reprogramming contribute to oncogene activation in IDH mutant gliomas.
Wang X; Dai L; Liu Y; Li C; Fan D; Zhou Y; Li P; Kong Q; Su J
Epigenetics Chromatin; 2023 Apr; 16(1):13. PubMed ID: 37118755
[TBL] [Abstract][Full Text] [Related]
12. PRMT1 driven PTX3 regulates ferritinophagy in glioma.
Lathoria K; Gowda P; Umdor SB; Patrick S; Suri V; Sen E
Autophagy; 2023 Jul; 19(7):1997-2014. PubMed ID: 36647288
[TBL] [Abstract][Full Text] [Related]
13. RARRES2 is Downregulated in Isocitrate Dehydrogenase 1 Mutant Glioma Patients and Served as an Unfavorable Prognostic Factor of Glioma.
Wang H; Wang X; Xu L; Zhang J
World Neurosurg; 2023 Aug; 176():e610-e622. PubMed ID: 37271257
[TBL] [Abstract][Full Text] [Related]
14. Stalled oligodendrocyte differentiation in IDH-mutant gliomas.
Wei Y; Li G; Feng J; Wu F; Zhao Z; Bao Z; Zhang W; Su X; Li J; Qi X; Duan Z; Zhang Y; Vega SF; Jakola AS; Sun Y; Carén H; Jiang T; Fan X
Genome Med; 2023 Apr; 15(1):24. PubMed ID: 37055795
[TBL] [Abstract][Full Text] [Related]
15. CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma.
Wang S; Wu J; Zhao W; Li M; Li S
FASEB J; 2023 Apr; 37(4):e22848. PubMed ID: 36906285
[TBL] [Abstract][Full Text] [Related]
16. Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
Viswanath P; Najac C; Izquierdo-Garcia JL; Pankov A; Hong C; Eriksson P; Costello JF; Pieper RO; Ronen SM
Oncotarget; 2016 Jun; 7(23):34942-55. PubMed ID: 27144334
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of the cuproptosis-related gene ATP7B in the prognosis and immune infiltration of IDH1 wild-type glioma.
Zhang K; Qu C; Zhou P; Yang Z; Wu X
Gene; 2024 May; 905():148220. PubMed ID: 38286269
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Immunohistochemical Expression of ALK-1 in Gliomas, WHO Grade 4 and Its Correlation with IDH1-R132H Mutation Status.
Khairy RA; Momtaz EM; Abd El Aziz AM; Shibel PEE
Asian Pac J Cancer Prev; 2024 Jan; 25(1):317-323. PubMed ID: 38285799
[TBL] [Abstract][Full Text] [Related]
19. Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.
Cordner R; Jhun M; Panwar A; Wang H; Gull N; Murali R; McAbee JH; Mardiros A; Sanchez-Takei A; Mazer MW; Fan X; Jouanneau E; Yu JS; Black KL; Wheeler CJ
Oncogene; 2023 Jun; 42(25):2088-2098. PubMed ID: 37161052
[TBL] [Abstract][Full Text] [Related]
20. IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.
Chen X; Liu J; Li Y; Zeng Y; Wang F; Cheng Z; Duan H; Pan G; Yang S; Chen Y; Li Q; Shen X; Li Y; Qin Z; Chen J; Huang Y; Wang X; Lu Y; Shu M; Zhang Y; Wang G; Li K; Lin X; Xing F; Zhang H
Nat Commun; 2023 Oct; 14(1):6781. PubMed ID: 37880243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
